OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
2.061
+0.051 (2.53%)
Jan 22, 2026, 12:43 PM EST - Market open
OmniAb Market Cap
OmniAb has a market cap or net worth of $296.66 million as of January 22, 2026. Its market cap has decreased by -33.38% in one year.
Market Cap
296.66M
Enterprise Value
263.16M
1-Year Change
-33.38%
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since October 25, 2022, OmniAb's market cap has decreased from $992.92M to $296.66M, a decrease of -70.12%. That is a compound annual growth rate of -31.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 289.35M | 8.65% |
| Dec 31, 2025 | 266.32M | -37.83% |
| Dec 31, 2024 | 428.38M | -40.30% |
| Dec 29, 2023 | 717.57M | 73.60% |
| Dec 30, 2022 | 413.36M | -58.37% |
| Oct 25, 2022 | 992.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avalo Therapeutics | 304.35M |
| Larimar Therapeutics | 301.71M |
| Rezolute | 293.95M |
| Neurogene | 293.14M |
| Cellectis | 293.11M |
| Achieve Life Sciences | 292.79M |
| Relmada Therapeutics | 290.40M |
| Abeona Therapeutics | 287.49M |